BioSpace News Archive

RaySearch Laboratories AB announces that the proton therapy machine vendor Ion Beam Applications S.A., has placed an order for RayStation®* treatment planning system and the oncology information system RayCare®* to be installed at nine proton centers in Spain.

Angiocrine Bioscience, Inc. today announced that it has been selected by the American Society of Hematology (ASH) for a poster presentation on its Phase 3 registration study AB-205-301 (E-CELERATE), a multi-center, randomized, double-blind, placebo-controlled study of AB-205 in adults with lymphoma undergoing high-dose chemotherapy (HDT) and autologous hematopoietic cell transplantation (AHCT).

One of the biggest threats to human health and life has always been cancer, and as instances rise each year, so do the financial and emotional burdens placed on patients and their families